Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Discovery of novel MAbs as promising COVID-19 immunotherapies

Aug. 18, 2020

Positive data presented from phase II study of F-351 in China

Aug. 18, 2020

TLC submits IND application in Taiwan for inhalable liposomal hydroxychloroquine for COVID-19

Aug. 18, 2020

Novavax initiates phase IIb efficacy trial of NVX-CoV2373 in South Africa

Aug. 17, 2020

Kiadis announces K-NK-cell technology program for the development of COVID-19 therapy

Aug. 17, 2020

Starpharma and Chase Sun to develop novel DEP nanoparticle formulations

Aug. 17, 2020

Dosing initiates in phase IIa study of ASC-22 in patients with chronic hepatitis B

Aug. 17, 2020

LION/repRNA-CoV2S vaccine candidate shows efficacy in vivo

Aug. 17, 2020

Ad26.COV2.S vaccine provides robust protection against SARS-CoV-2 in rhesus macaques

Aug. 14, 2020

Starving out Chlamydia

Aug. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...